News
Dr. Shailesh Shahi awarded three-year grant from the Department of Defense Multiple Sclerosis Research Program to investigate microbiota-targeted strategies for reducing obesity-driven multiple sclerosis severity
Monday, August 4, 2025
Dr. Shailesh Shahi has been awarded a three-year, $999,265 grant from the Department of Defense Multiple Sclerosis Research Program (DoD-MSRP) for his project titled “Impact of Obesity-Driven Gut Microbiota Alterations on Multiple Sclerosis.”
Dr. Shailesh Shahi receives three-year research grant from the National Multiple Sclerosis Society to investigate obesity’s impact on gut microbiota and MS severity
Monday, June 2, 2025
Dr. Shailesh Shahi has been awarded a three-year research grant from the National Multiple Sclerosis Society (NMSS) for his project titled, “Determining how obesity alters the gut microbiota to drive the severity of CNS autoimmune inflammatory disease.”
Dr. Shailesh Shahi, Stephanie Peterson and Ti-Ara Turner from Dr. Mangalam’s Laboratory Win Travel Awards for the 2023 Annual American Association of Immunology Meeting
Friday, May 5, 2023
Dr. Shailesh K. Shahi (Faculty Associate) received an American Association of Immunology (AAI) Early Career Faculty Travel Grant to attend the upcoming annual AAI meeting in Washington D.C. In addition, Stephanie Peterson received an AAI Trainee Abstract Award and Ti-Ara Turner received an AAI Trainee Poster Award to attend the same meeting.
Dr. Shailesh Shahi intervewed by MStranslate
Wednesday, December 2, 2020
Dr. Shailesh Shahi was interviewed by MSTranslate in the presentation "The Gut Microbiome: A Novel Treatment Approach For Multiple Sclerosis." Watch the the interview here!
Shailesh Shahi and Samantha Freedman Wins Presentation and Travel Awards for the 2020 Annual Association of Immunology Meeting
Tuesday, March 10, 2020
Dr. Shailesh Shahi was awarded a podium presentation and American Association of Immunologists (AAI) Trainee Travel Award to present his findings entitled “Microbiota-driven regulatory T cells suppress experimental autoimmune encephalomyelitis (EAE) in interleukin-17A deficient HLA class-II transgenic mice as a model of multiple sclerosis (MS)” at the upcoming AAI meeting in Honolulu, Hawaii.
Dr. Shailesh Shahi receives an Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Educational Travel Award
Monday, December 18, 2017
Dr. Shailesh Shahi has been awarded an Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Educational Travel Award to present his research findings at the 2018 ACTRIMS Forum meeting in San Diego, California.
Dr. Shailesh K. Shahi has been awarded an American Association of Immunologists (AAI) Trainee Travel Award
Saturday, April 29, 2017
Shailesh K. Shahi will present his research findings at the 2017 Annual AAI meeting in Washington D.C. He is working on a research project to decipher the role of gut microbiota in an animal model of multiple sclerosis.
Dr. Shailesh K. Shahi received the Multiple Sclerosis Society’s (NMSS) Travel Award
Monday, November 21, 2016
Shailesh K. Shahi has been awarded the Multiple Sclerosis Society’s (NMSS) Travel Award for 2016 Autumn Immunology Conference, held in Chicago November 18-21, 2016. He is working on a research project to decipher role of gut microbiota in modulation of multiple sclerosis (MS) in its animal model.